“By accessing IDT’s technologies and expertise, we can provide high-quality sequencing data to our clients.
This partnership will further us in the journey of novel NGS research and eventually provide cancer researchers with more insights around treatment options.”
Dr. Xue Wu — President & CEO
Geneseeq Canada
READ MORE GENESEEQ
